Bloomberg News is looking for an ambitious news breaker to cover the biggest US drug companies: Pfizer, J&J, Bristol-Myers and Merck, which are all in various stages of trying to reinvent themselves as some of their blockbuster drugs face generic competition later this decade.
You are an experienced and versatile reporter who can break news on dynamic and evolving corporate stories, analyze and translate scientific research and breakthroughs, and keep tabs on the enormous power the pharma industry wields as the largest industry lobby in Washington. You are motivated by scoops and the ability to conceive and execute ambitious enterprise and investigative projects that map out the future of big pharma.
To apply, go here.
Former CoinDesk editorial staffer Michael McSweeney writes about the recent happenings at the cryptocurrency news site, where…
Manas Pratap Singh, finance editor for LinkedIn News Europe, has left for a new opportunity…
Washington Post executive editor Matt Murray sent out the following on Friday: Dear All, Over the last…
The Financial Times has hired Barbara Moens to cover competition and tech in Brussels. She will start…
CNBC.com deputy technology editor Todd Haselton is leaving the news organization for a job at The Verge.…
Note from CNBC Business News senior vice president Dan Colarusso: After more than 27 years…